Fol. Biol. 2005, 51, 85-88
https://doi.org/10.14712/fb2005051040085
Milestones in the Field of Tumour Microenvironment Contributions and Perspectives of Professor Isaac P. Witz
References
1. , R., Neumark, E., Sagi-Assif, O., Witz, I. P. (2002) Receptors involved in microenvironment-driven molecular evolution of cancer cells. Semin. Cancer Biol. 12, 139-147.
<https://doi.org/10.1006/scbi.2001.0422>
2. , O., Sagi-Assif, O., Raanani, P., Avigdor, A., Ben-Bassat, I., Witz, I. P. (2003) cDNA microarray analysis reveals an overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia. Methods Enzymol. 366, 103-113.
<https://doi.org/10.1016/S0076-6879(03)66009-X>
3. , M., Witz, I. P. (1984) The significance of tumor associated anti T cell antibodies for tumor-host immune relationship. Leukemia Rev. 2, 151-171.
4. , M., Yaakubowicz, M., Amitai, O., Witz, I. P. (1980) Tumor-localizing lymphocytotoxic antibodies. Contemp. Top. Immunobiol. 10, 191-211.
5. , S. W., Witz, I. P., Herberman, R. B. (1980) A review of data, problems, and open questions pertaining to in situ tumor immunity. Contemp. Top. Immunobiol. 10, 1-20.
6. , I. P. (1971) Tumor-associated immunoglobulins. Isr. J. Med. Sci. 7, 230-238.
7. , I. P. (1973) The biological significance of tumor-bound immunoglobulins. Curr. Top. Microbiol. Immunol. 61, 151-171.
8. , I. P. (1977) Tumor-bound immunoglobulins: in situ expressions of humoral immunity. Adv. Cancer Res. 25, 95-148.
<https://doi.org/10.1016/S0065-230X(08)60633-8>
9. Witz, I. P. (1996) The shaping of a malignancy phenotype by microenvironmental host factors. In: Recent Advances in Gastroenterological Carcinogenesis, eds. Tahara, I. F., Sugimachi, K., Oohara, T., pp. 287-294, Monduzzi Editore, Bologna.
10. , I. P. (2000) Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins. J. Cell. Biochem. 34, (Suppl.) 61-66.
<https://doi.org/10.1002/(SICI)1097-4644(2000)77:34+<61::AID-JCB11>3.0.CO;2-S>
11. , I. P. (2001) Presence and functions of immune components in the tumor microenvironment. Adv. Exp. Med. Biol. 495, 317-324.
<https://doi.org/10.1007/978-1-4615-0685-0_44>
12. , I. P. (2002) The tumour microenvironment - Introduction. Semin. Cancer Biol. 12, 87-88.
<https://doi.org/10.1006/scbi.2001.0415>
13. , I. P., Ran, M. (1985) Could Fc-receptors facilitate the escape of immunogenic premalignant cells from host defence? A hypothesis. Ann. Inst. Pasteur 136C, 423-428.
<https://doi.org/10.1016/S0769-2625(85)80020-9>
14. Witz, I. P., Sagi-Assif, O., Ran, M. (1996) The shaping of the malignancy phenotype an interplay between cellular characteristics and microenvironmental factors. In: Premalignancy and Tumor Dormancy, eds. Yefenof, E., Scheuermann, R. H., pp. 147-156, Medical Intelligence Unit, R.G. Landes Co.
15. , A., Israeli-Amit, M., Meshel, T., Sagi-Assif, O., Yron, I., Lifshitz, V., Bacharach, E., Smorodinsky, N. I., Many, A., Czernilofsky, P. A., Morton, D. L., Witz, I. P. (2004) Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Cancer Res. 64, 6571-6578.
<https://doi.org/10.1158/0008-5472.CAN-03-4038>
